Synthesis and biological activity of some substituted 2-phenyl-quinazolin- 4-ones

Asian Journal of Chemistry

Volumn 17, Issue 1, 2005, Pages 57-65

  Raghavendra, N M ^a   Niranjan, M S ^a   Venkatesh, P ^a   Prashantha Kumar, B R ^a   Gowda, Narendra B ^a   Sripathi, M S ^a  

^a Government College of Pharmacy   (India)

Author keywords

Biological activity; Substituted 2 phenyl quinazolin 4 ones; Synthesis

Indexed keywords

2 PHENYL QUINAZOLIN 4 ONE DERIVATIVE; 6 BROMO 2 PHENYL 3 (2 CHLORO BENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 (3 NITRO BENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 (4 CARBOXYBENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 (4 CHLORO BENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 (4 HYDROXY 3 METHOXYBENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 (4 METHOXY BENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 (4 N,N' DIMETHYLAMINOBENZALAMINO)QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 AMINO QUINAZOLIN 4(3H) ONE; 6 BROMO 2 PHENYL 3 BENZALAMINO QUINAZOLIN 4(3H) ONE; AMINE; BROMINE; PHENYL GROUP; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG; VINCRISTINE;

AGAR GEL DIFFUSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LIFESPAN; MOUSE; NONHUMAN;

EID: 15244345877     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. V.K. Srivastava, S. Singh, A. Gucati and K. Shankar, Indian J. Chem., 26B, 652 (1987).
2. D.P. Gupta, S. Ahmad, A. Kumar and K. Shankar, Indian J. Chem., 27B, 1060 (1988).
3. M.R. Chaurasia and A.K. Sharma, J. Indian Chem. Soc., 62, 308 (1985).
4. D.D. Mukherji, S.R. Nautiyal, C.R. Prasad and B.N. Dhawan, Indian J. Med. Res., 71, 480 (1980).
5. V. Joshi and R.P. Chaudari, Indian J. Chem., 26B, 602 (1987).
6. V.J. Ram, R.C. Srimal, D.S. Kushwaha and L.J. Mishra, J. Prakt. Chem., 332, 629 (1990).
7. N. Tiwari, B. Chaturvedi and Nizamuddin, Indian J. Chem., 28B, 200 (1989).
8. H.J. Yale and M. Kalkstein, J. Med. Chem., 10, 334 (1967).
9. G.L. Neil, L.H. Li, H.H. Buskirk and T.E. Moxley, Cancer Chemotherapy, 56, 163 (1972).
10. J.B. Jiang, D.P. Hesson, B.A. Dusak, D.L. Dexter, G.J. Kang and E. Hamel, J. Med. Chem., 33, 1721 (1990).
11. C.M. Lin, G.J. Kang, M.C. Roach, J.B. Jiang, D.P. Hesson, R.F. Luduena and E. Hamel, Molecular Pharmacol., 40, 827 (1991).
12. M.J. Hour, L.J. Huang, S.C. Kuo, Y. Xia, K. Bestow, Y. Nakanishi, E. Hamel and K.H. Lee, J. Med. Chem., 43, 4479 (2000).
13. B.R. Shah, J.J. Bhatt, H.H. Patel, N.K. Undavia, P.B. Trivedi and N.C. Desai, Indian J. Chem., 34B, 201 (1995).
14. A.S. Wheeler and W.M. Oates, J. Am. Chem. Soc., 770 (1910).
15. A.C. Sharada, F.E. Solomon, P. Uma Devi, N. Udupa and K.K. Srinivasan, Acta Oncologica, 35, 95 (1996).
16. J.K. Khanam, S.R Bag, B. Sur and P. Sur, Indian J. Pharmacol., 29, 157 (1997).
17. R. Cruickcshank, J.D. Dugid, D.P. Marmion and R.H.A. Swain, Medical Microbiology, Vol. 2, Churchill-Livingstone, Edinburgh-London (1975).